Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults over 18 years old, of any gender
- People without liver scarring (cirrhosis) who have had liver cancer confirmed by a tissue biopsy within the past month before surgery, OR people with liver scarring whose liver cancer has been identified using a specialised MRI or CT scan showing characteristic patterns of the disease
- People with no more than 3 tumours, where at least one tumour measures between 3.1 and 5.0 cm at its widest point
- People whose cancer has not spread into blood vessels, lymph nodes, or other parts of the body
- People whose liver is functioning at an acceptable level, based on a standard liver scoring system called Child-Pugh A or B, assessed within 14 days before surgery
- People who understand the purpose of the study and are willing to sign a consent form to participate
Who may not be able to join:
- People whose liver has stopped working properly, or who have had confusion related to liver failure, a large build-up of fluid in the abdomen, or bleeding from the digestive tract within the past month
- People with blood clotting problems, including a platelet count below 50 x 10⁹/L or a blood clotting measurement (INR) above 1.5
- People with serious heart, lung, or kidney problems
- People who currently have an active infection
- People who are pregnant
- People with a history of substance abuse or mental illness
- People whose body cannot tolerate the type of gas inflation used during keyhole (laparoscopic) surgery (confirm with trial site)
- People who have taken part in another clinical study or received anti-cancer treatment in the four weeks before joining this study
- People whom the trial researchers consider unsuitable for any other reason that could affect safe participation
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ping Liang, Doctor, Chinese PLA General Hospital
Phone: 8601066939530
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Overall survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.